2024-06-14 This Week in Metastatic Breast Cancer Metastatic Breast Cancer Week in Review Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients 2024 Jun 11Commentary by Lillie Shockney RN, BS, MAS, HON-ONN-CG Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial 2024 Jun 12Commentary by Reshma Mahtani DO Health-related quality of life with sacituzumab govitecan in HR+/HER2- metastatic breast cancer in the phase III TROPiCS-02 trial 2024 Jun 10Commentary by Lillie Shockney RN, BS, MAS, HON-ONN-CG ASCO 2024: Lerociclib Plus Letrozole a Viable Treatment Option for HR-Positive/HER2-Negative Advanced or Metastatic Breast Cancer 2024 Jun 10 ASCO 2024: Surgery for De Novo Metastatic Breast Cancer Less Frequent in 2019 Versus 2010 2024 Jun 10 回上一頁
